GE HealthCare Technologies Inc. with ticker code (GEHC) have now 13 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $103.00 and $86.00 with the average share target price sitting at $94.63. (at the time of writing). Given that the stocks previous close was at $88.47 this now indicates there is a potential upside of 7.0%. There is a 50 day moving average of $86.60 and the 200 moving average now moves to $75.77. The company has a market capitalization of 40.02B. The stock price for the company is currently is currently $87.71 USD
The potential market cap would be $42,811,359,507 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 28.85, revenue per share of $42.97 and a 6.15% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
